تاثیر دوازده هفته تمرین ترکیبی (هوازی + مقاومتی) بر سطوح آیریزین و مقاومت به انسولین در زنان چاق غیرفعال

1-Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Annals of internal medicine. 2013;159(11):758-69.

2-Bahrami H, Sadatsafavi M, Pourshams A, Kamangar F, Nouraei M, Semnani S, et al. Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC public health. 2006;6(1):158.

3-Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. Journal of Clinical Investigation. 2016;126(1):12.

4-Kang D-W, Lee J, Suh S-H, Ligibel JA, Courneya KS, Jeon JY. Effects of Exercise on Insulin, IGF-axis, Adipocytokines, and Inflammatory Markers in Breast Cancer Survivors: A Systematic Review and Meta-Analysis. Cancer Epidemiology and Prevention Biomarkers. 2016:cebp. 0602.2016.

5-Xu A. Chronic exercise alleviates obesity-related metabolic dysfunction by enhancing FGF21 sensitivity in adipose tissues. Diabetes Research and Clinical Practice. 2016;120:S24.

6-Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nature Reviews Endocrinology. 2012;8(8):457-65.

7-Varela-Rodríguez B, Pena-Bello L, Juiz-Valiña P, Vidal-Bretal B, Cordido F, Sangiao-Alvarellos S. FNDC5 expression and circulating irisin levels are modified by diet and hormonal conditions in hypothalamus, adipose tissue and muscle. Scientific reports. 2016;6.

8-Seale P, Conroe HM, Estall J, Kajimura S, Frontini A, Ishibashi J, et al. Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. The Journal of clinical investigation. 2011;121(1):96-105.

9-Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, et al. A PGC1-[agr]-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481(7382):463-8.

10-Choi Y-K, Kim M-K, Bae KH, Seo H-A, Jeong J-Y, Lee W-K, et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes research and clinical practice. 2013;100(1):96-101.

11-Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012;61(12):1725-38.

12-Reisi J, Rajabi H, Ghaedi K, Marandi S-M, Dehkhoda M-R. Effect of Acute Resistance Training on Plasma Irisin Protein Level and Expression of Muscle FNDC5 and Adipose Tissue UCP1 Genes in Male Rats. Journal of Isfahan Medical School. 2013;31(256).

13-Kraemer RR, Shockett P, Webb ND, Shah U, Castracane VD. A transient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women. Hormone and metabolic research. 2014;46(02):150-4.

14-Norheim F, Langleite TM, Hjorth M, Holen T, Kielland A, Stadheim HK, et al. The effects of acute and chronic exercise on PGC‐1α, irisin and browning of subcutaneous adipose tissue in humans. FEBS Journal. 2014;281(3):739-49.

15-Pekkala S, Wiklund PK, Hulmi JJ, Ahtiainen JP, Horttanainen M, Pöllänen E, et al. Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health? The Journal of physiology. 2013;591(21):5393-400.

16-Ellefsen S, Vikmoen O, Slettaløkken G, Whist JE, Nygård H, Hollan I, et al. Irisin and FNDC5: effects of 12-week strength training, and relations to muscle phenotype and body mass composition in untrained women. European journal of applied physiology. 2014;114(9):1875-88.

17-Hecksteden A, Wegmann M, Steffen A, Kraushaar J, Morsch A, Ruppenthal S, et al. Irisin and exercise training in humans–results from a randomized controlled training trial. BMC medicine. 2013;11(1):235.

18-Association AD. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes care. 2002;25(1):202-12.

19-Tanaka H, Monahan KD, Seals DR. Age-predicted maximal heart rate revisited. Journal of the American College of Cardiology. 2001;37(1):153-6.

20-Karvonen J, Vuorimaa T. Heart rate and exercise intensity during sports activities. Sports Medicine. 1988;5(5):303-11.

21-Assarzade Noushabadi M, Abedi B. Effects of combination training on insulin resistance index and some inflammatory markers in inactive men. The Horizon of Medical Sciences. 2012;18(3):95-105.

22-Boström PA, Fernández-Real JM, Mantzoros C. Irisin in humans: recent advances and questions for future research. Metabolism-Clinical and Experimental. 2014;63(2):178-80.

23-Tsuchiya Y, Ando D, Goto K, Kiuchi M, Yamakita M, Koyama K. High-intensity exercise causes greater irisin response compared with low-intensity exercise under similar energy consumption. The Tohoku journal of experimental medicine. 2014;233(2):135-40.

24-Blüher S, Panagiotou G, Petroff D, Markert J, Wagner A, Klemm T, et al. Effects of a 1‐year exercise and lifestyle intervention on irisin, adipokines, and inflammatory markers in obese children. Obesity. 2014;22(7):1701-8.

25-Miyamoto-Mikami E, Sato K, Kurihara T, Hasegawa N, Fujie S, Fujita S, et al. Endurance training-induced increase in circulating irisin levels is associated with reduction of abdominal visceral fat in middle-aged and older adults. PloS one. 2015;10(3):e0120354.

26-Arora E, Shenoy S, Sandhu J. Effects of resistance training on metabolic profi le of adults with type 2 diabetes. 2009.

27-Crujeiras AB, Pardo M, Arturo RR, Santiago NC, Zulet M, Martínez JA, et al. Longitudinal variation of circulating irisin after an energy restriction‐induced weight loss and following weight regain in obese men and women. American Journal of Human Biology. 2014;26(2):198-207.

28-Hee Park K, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, Joung KE, et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. The Journal of Clinical Endocrinology & Metabolism. 2013;98(12):4899-907.